Papaloisou to market Librax
Date: 11 Jul 2012

C.G. Papaloisou Ltd has commenced marketing and distribution of Librax® tablets (clidinium bromide / chlordiazepoxide) in Cyprus. The product is supplied by MEDA of Sweden. Librax is intended for the symptomatic treatment of severe and/or incapacitating signs of anxiety accompanied by digestive function disorders with a spasmodic component.

For more information about Librax click here.